
Sean M. Basquill
Examiner (ID: 6963, Phone: (571)270-5862 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1612, 1614, 1613 |
| Total Applications | 1332 |
| Issued Applications | 496 |
| Pending Applications | 114 |
| Abandoned Applications | 739 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19762133
[patent_doc_number] => 12220403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 18/484334
[patent_app_country] => US
[patent_app_date] => 2023-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9871
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484334
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/484334 | Pharmaceutical composition | Oct 9, 2023 | Issued |
Array
(
[id] => 20341878
[patent_doc_number] => 12465593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 18/484337
[patent_app_country] => US
[patent_app_date] => 2023-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5954
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484337
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/484337 | Pharmaceutical composition | Oct 9, 2023 | Issued |
Array
(
[id] => 19187723
[patent_doc_number] => 20240166636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/471734
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18471734
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/471734 | CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME | Sep 20, 2023 | Pending |
Array
(
[id] => 18892999
[patent_doc_number] => 20240008484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => Aqueous Co-Formulation of Metalaxyl
[patent_app_type] => utility
[patent_app_number] => 18/369298
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18369298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/369298 | Aqueous Co-Formulation of Metalaxyl | Sep 17, 2023 | Abandoned |
Array
(
[id] => 19263498
[patent_doc_number] => 20240207195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => OCULAR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/458828
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458828
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/458828 | OCULAR DRUG DELIVERY | Aug 29, 2023 | Pending |
Array
(
[id] => 19111264
[patent_doc_number] => 20240123014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => NATURAL COMBINATION PRODUCTS AND METHODS FOR REGULATION OF KIDNEY AND EXCRETORY SYSTEM FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/457080
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18457080
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/457080 | Natural combination products and methods for regulation of kidney and excretory system function | Aug 27, 2023 | Issued |
Array
(
[id] => 18842675
[patent_doc_number] => 20230405079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => LISINOPRIL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/450553
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450553 | Lisinopril formulations | Aug 15, 2023 | Issued |
Array
(
[id] => 20142732
[patent_doc_number] => 12377047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Emulsions for treating mucous membrane infections
[patent_app_type] => utility
[patent_app_number] => 18/233560
[patent_app_country] => US
[patent_app_date] => 2023-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2893
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18233560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/233560 | Emulsions for treating mucous membrane infections | Aug 13, 2023 | Issued |
Array
(
[id] => 20039244
[patent_doc_number] => 20250177466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => DIETARY COMPOSITIONS TO EXTEND LONGEVITY WHILE MAXIMIZING STRENGTH AND FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/287381
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287381
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287381 | DIETARY COMPOSITIONS TO EXTEND LONGEVITY WHILE MAXIMIZING STRENGTH AND FUNCTION | Aug 6, 2023 | Pending |
Array
(
[id] => 19081826
[patent_doc_number] => 20240108627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => Phosphodiesterase Inhibitor Treatment
[patent_app_type] => utility
[patent_app_number] => 18/229694
[patent_app_country] => US
[patent_app_date] => 2023-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18229694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/229694 | Phosphodiesterase Inhibitor Treatment | Aug 2, 2023 | Abandoned |
Array
(
[id] => 18953431
[patent_doc_number] => 20240041758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE
[patent_app_type] => utility
[patent_app_number] => 18/227463
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/227463 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine | Jul 27, 2023 | Issued |
Array
(
[id] => 19001898
[patent_doc_number] => 20240065969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/359642
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18359642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/359642 | OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF | Jul 25, 2023 | Pending |
Array
(
[id] => 18769610
[patent_doc_number] => 20230364380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => CATHETER LOCK SOLUTION COMPRISING SODIUM CITRATE AND BENZYL ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 18/356331
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/356331 | Catheter lock solution comprising sodium citrate and benzyl alcohol | Jul 20, 2023 | Issued |
Array
(
[id] => 19001971
[patent_doc_number] => 20240066042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
[patent_app_type] => utility
[patent_app_number] => 18/357004
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357004 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | Jul 20, 2023 | Abandoned |
Array
(
[id] => 20607031
[patent_doc_number] => 12582610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Lipid-polymer compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/223187
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15111
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18223187
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/223187 | Lipid-polymer compositions and methods of use | Jul 17, 2023 | Issued |
Array
(
[id] => 19331373
[patent_doc_number] => 20240245803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => NANOPARTICLE AND USE THEREOF FOR THE COMBINATORIAL THERAPY OF ENDOPLASMIC RETICULUM STRESS INDUCER AND IMMUNOTHERAPEUTIC TO TUMORS AND IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/353723
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/353723 | Nanoparticle and use thereof for the combinatorial therapy of endoplasmic reticulum stress inducer and immunotherapeutic to tumors and immune cells | Jul 16, 2023 | Issued |
Array
(
[id] => 18752418
[patent_doc_number] => 20230355661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/222690
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222690
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222690 | Bi-functional co-polymer use for ophthalmic and other topical and local applications | Jul 16, 2023 | Issued |
Array
(
[id] => 19423719
[patent_doc_number] => 12083110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Nicotine lozenge
[patent_app_type] => utility
[patent_app_number] => 18/344198
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 8404
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344198 | Nicotine lozenge | Jun 28, 2023 | Issued |
Array
(
[id] => 18675241
[patent_doc_number] => 20230312837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => POLYMERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/208029
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208029 | POLYMERS AND USES THEREOF | Jun 8, 2023 | Pending |
Array
(
[id] => 19225509
[patent_doc_number] => 12005139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Ophthalmic formulations and related methods
[patent_app_type] => utility
[patent_app_number] => 18/207339
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18996
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18207339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/207339 | Ophthalmic formulations and related methods | Jun 7, 2023 | Issued |